These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 19109014)

  • 21. Proximity of a Tat peptide to the HIV-1 TAR RNA loop region determined by site-specific photo-cross-linking.
    Wang Z; Huq I; Rana TM
    Bioconjug Chem; 1999; 10(3):512-9. PubMed ID: 10346885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and bioactivities of TAR RNA targeting beta-carboline derivatives based on Tat-TAR interaction.
    Yu X; Lin W; Pang R; Yang M
    Eur J Med Chem; 2005 Sep; 40(9):831-9. PubMed ID: 15925430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Tat and anti-HIV activities of trimers of n-alkylglycines.
    Márquez N; Sancho R; Macho A; Moure A; Masip I; Messeguer A; Muñoz E
    Biochem Pharmacol; 2006 Feb; 71(5):596-604. PubMed ID: 16405868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides.
    Tripathi S; Chaubey B; Ganguly S; Harris D; Casale RA; Pandey VN
    Nucleic Acids Res; 2005; 33(13):4345-56. PubMed ID: 16077030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probing interaction of a fluorescent ligand with HIV TAR RNA.
    Qi L; Zhang J; He T; Huo Y; Zhang ZQ
    Spectrochim Acta A Mol Biomol Spectrosc; 2017 Feb; 173():93-98. PubMed ID: 27611591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and biological evaluation of substituted guanidine indole derivatives as potential inhibitors of HIV-1 Tat-TAR interaction.
    Wang J; Wang Y; Li Z; Zhan P; Bai R; Pannecouque C; Balzarini J; De Clercq E; Liu X
    Med Chem; 2014; 10(7):738-46. PubMed ID: 24605773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron(II) supramolecular helicates interfere with the HIV-1 Tat-TAR RNA interaction critical for viral replication.
    Malina J; Hannon MJ; Brabec V
    Sci Rep; 2016 Jul; 6():29674. PubMed ID: 27405089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, and biological activity of a cyclic peptide: an inhibitor of HIV-1 tat-TAR interactions in human cells.
    Tamilarasu N; Huq I; Rana TM
    Bioorg Med Chem Lett; 2000 May; 10(9):971-4. PubMed ID: 10853671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat.
    Mediouni S; Chinthalapudi K; Ekka MK; Usui I; Jablonski JA; Clementz MA; Mousseau G; Nowak J; Macherla VR; Beverage JN; Esquenazi E; Baran P; de Vera IMS; Kojetin D; Loret EP; Nettles K; Maiti S; Izard T; Valente ST
    mBio; 2019 Feb; 10(1):. PubMed ID: 30723126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metal-Enhanced Aggregation-Induced Emission Strategy for the HIV-I RNA-Binding Ligand Assay.
    Li J; Fan YY; Wen J; Zhang J; Zhang ZQ
    Anal Chem; 2022 Mar; 94(11):4695-4702. PubMed ID: 35258935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of each guanidinium group on the RNA recognition and cellular uptake of Tat-derived peptides.
    Wu CH; Weng MH; Chang HC; Li JH; Cheng RP
    Bioorg Med Chem; 2014 Jun; 22(11):3016-20. PubMed ID: 24767816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel Time-Resolved Fluorescence Resonance Energy Transfer Assay for the Discovery of Small-Molecule Inhibitors of HIV-1 Tat-Regulated Transcription.
    Shin YH; Kim DE; Yu KL; Park CM; Kim HG; Kim KC; Bae S; Yoon CH
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies of anti-HIV transcription inhibitor quinolones: identification of potent N1-vinyl derivatives.
    Tabarrini O; Massari S; Daelemans D; Meschini F; Manfroni G; Bottega L; Gatto B; Palumbo M; Pannecouque C; Cecchetti V
    ChemMedChem; 2010 Nov; 5(11):1880-92. PubMed ID: 20928882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metallo supramolecular cylinders inhibit HIV-1 TAR-TAT complex formation and viral replication in cellulo.
    Cardo L; Nawroth I; Cail PJ; McKeating JA; Hannon MJ
    Sci Rep; 2018 Sep; 8(1):13342. PubMed ID: 30190568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of lysine methylation and acetylation on the RNA recognition and cellular uptake of Tat-derived peptides.
    Liu MC; Chen CY; Chiang CH; Wang WM; Cheng RP
    Bioorg Med Chem; 2016 Nov; 24(21):5047-5051. PubMed ID: 27670097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thermodynamic studies of a series of homologous HIV-1 TAR RNA ligands reveal that loose binders are stronger Tat competitors than tight ones.
    Pascale L; Azoulay S; Di Giorgio A; Zenacker L; Gaysinski M; Clayette P; Patino N
    Nucleic Acids Res; 2013 Jun; 41(11):5851-63. PubMed ID: 23605042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1 TAT and IMMUNE DYSREGULATION in AIDS PATHOGENESIS: a THERAPEUTIC TARGET.
    Chiozzini C; Toschi E
    Curr Drug Targets; 2016; 17(1):33-45. PubMed ID: 26302810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TAR RNA Mediated Folding of a Single-Arginine-Mutant HIV-1 Tat Protein within HeLa Cells Experiencing Intracellular Crowding.
    Kim JM; Chun H
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral properties of quinolone-based drugs.
    Richter S; Parolin C; Palumbo M; Palù G
    Curr Drug Targets Infect Disord; 2004 Jun; 4(2):111-6. PubMed ID: 15180459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Forced intercalation-induced light-up peptides as fluorogenic indicators for the HIV-1 TAR RNA-ligand assay.
    Lee ETT; Sato Y; Ujuagu AF; Nishizawa S
    Analyst; 2024 Jun; ():. PubMed ID: 38860915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.